|
2025
|
Invention
|
Anti-cldn6 antibody, antibody-drug conjugate thereof, and medical use thereof. Provided are an an... |
|
|
Invention
|
Pharmaceutically acceptable salt of g12d inhibitor compound and crystal form thereof. The present... |
|
|
Invention
|
Crystal form of g12d inhibitor compound and preparation method. The present invention relates to ... |
|
|
Invention
|
Glp-1r agonist pharmaceutical composition and use thereof. Disclosed are a GLP-1R agonist pharmac... |
|
2024
|
Invention
|
Antibody-polypeptide conjugate and pharmaceutical use thereof. An antibody-polypeptide conjugate ... |
|
|
Invention
|
Pharmaceutical composition comprising bispecific antibody specifically binding dll3 and cd3. Prov... |
|
|
Invention
|
Olefin compound, preparation method therefor and use thereof in medicine. The present disclosure ... |
|
|
Invention
|
Cd3-targeting antibody and use thereof. The present invention provides an antibody specifically b... |
|
|
Invention
|
Heterocyclic compound, and preparation method therefor and use thereof in medicine. The present d... |
|
|
Invention
|
Method for preparing heterologous multimer by means of recombination reaction. The present disclo... |
|
|
Invention
|
Fused heteroaryl compound, preparation method therefor, and use thereof in medicine. The present ... |
|
|
Invention
|
Pharmaceutical composition of sulfonylurea derivative. The present disclosure provides a pharmace... |
|
|
Invention
|
Pharmaceutical composition comprising anti-tslp antibody and use thereof. The present invention r... |
|
|
Invention
|
Amide-substituted cycloalkyl compounds, preparation method therefor and medical uses thereof. The... |
|
|
Invention
|
Pharmaceutically acceptable salt and crystalline form of quinazoline derivative, and use thereof.... |
|
|
Invention
|
Crystalline form of quinazoline derivative and preparation method therefor. A crystalline form of... |
|
|
Invention
|
Heterocyclic compound, preparation method therefor and medical use thereof. The present disclosur... |
|
|
Invention
|
Heteroaryl compound, and preparation method therefor and use thereof in medicine. Provided are a ... |
|
|
Invention
|
Pharmaceutical composition comprising bispecific antibody specifically binding to gprc5d and cd3.... |
|
|
Invention
|
Fused heteroaryl compound, and preparation method therefor and use thereof in medicine. A fused h... |
|
|
Invention
|
Heteroaryl compound, preparation method therefor, and use thereof in medicine. A heteroaryl compo... |
|
|
Invention
|
Anti-psma antibody-drug conjugate and pharmaceutical use thereof. An anti-PSMA antibody-drug conj... |
|
|
Invention
|
Anti-npr1 antibody and pharmaceutical use thereof. Provided are an anti-NPR1 antibody, a pharmace... |
|
2023
|
Invention
|
Pharmaceutical composition containing isoquinolinone compound, and preparation method therefor. T... |
|
|
Invention
|
Pharmaceutical composition comprising kras g12d inhibitor. The present disclosure relates to a ph... |
|
|
Invention
|
Fused ring compound, preparation method therefor and medicinal application thereof. The present d... |
|
|
Invention
|
Pharmaceutically acceptable salt and crystal form of nitrogen-containing bridge heterocyclic deri... |
|
|
Invention
|
Antigen-binding molecule specifically binding to dll3 and cd3, and pharmaceutical use thereof. Th... |
|
|
Invention
|
Crystal forms of triazine dione derivative and preparation method therefor. The present disclosur... |
|
|
Invention
|
Pharmaceutical composition containing anti-nectin-4 antibody drug conjugate and use thereof. Prov... |
|
|
Invention
|
Nitrogen-containing heterocyclic compound, preparation method therefor, and pharmaceutical applic... |
|
|
Invention
|
Fused heterocyclic compound, and preparation method therefor and medical use thereof.
The presen... |
|
|
Invention
|
Antigen-binding molecule specifically binding to gprc5d and cd3 and medical use thereof.
Provide... |
|
|
Invention
|
Antigen-binding molecule specifically binding to gprc5d and cd3 and medical use thereof. Provided... |
|
|
Invention
|
Antigen-binding molecule specifically binding to psma and cd3, and pharmaceutical use thereof.
P... |
|
|
Invention
|
Crystalline form of sulfur-containing isoindoline derivative. The present disclosure relates to a... |
|
|
Invention
|
Crystalline form of sulfur-containing isoindoline derivative.
The present disclosure relates to ... |
|
2022
|
Invention
|
Anti-ror1 antibody, and anti-ror1 antibody-drug conjugate and medical uses thereof.
An anti-ROR1... |
|
|
Invention
|
Anti-dll3 antibody and pharmaceutical use thereof, and antibody-drug conjugate containing anti-dl... |
|
|
Invention
|
Pharmaceutically acceptable salt and crystalline form of glp-1 receptor agonist and preparation m... |
|
|
Invention
|
Crystalline form of glp-1 receptor agonist and preparation method therefor.
A crystalline form o... |
|
|
Invention
|
Anti-sost antibody pharmaceutical composition and use thereof.
The present invention relates to ... |
|
|
Invention
|
Chimeric compound for targeted degradation of androgen receptor protein, preparation method there... |
|
|
Invention
|
Nitrogen-containing tetracyclic compound, preparation method therefor, and medical use thereof.
... |
|
|
Invention
|
Anti-il23 antibody fusion protein and uses thereof.
An anti-IL23 antibody fusion protein and use... |
|
|
Invention
|
Fused bicyclic derivative, pharmaceutically acceptable salt, crystal form thereof and preparation... |
|
|
Invention
|
Sulfonamide derivative, preparation method therefor and medical use thereof.
Provided is a sulfo... |
|
|
Invention
|
Tetrahydronaphthalene compound, and preparation method therefor and use thereof in medicine.
The... |
|
2021
|
Invention
|
Nitrogen-containing bridged heterocyclic compound, preparation method therefor, and medical use t... |
